NOV-ERA – A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn’s Disease

​ Conditions: Fibrostenotic Crohn’s Disease

Interventions: Drug: Ontunisertib; Drug: Ontunisertib; Drug: Ontunisertib; Drug: Placebo

Sponsors: Agomab Spain S.L.U.

Not yet recruiting Conditions: Fibrostenotic Crohn’s Disease
Interventions: Drug: Ontunisertib; Drug: Ontunisertib; Drug: Ontunisertib; Drug: Placebo
Sponsors: Agomab Spain S.L.U.
Not yet recruiting